Cargando…
Withdrawal notice to: “Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data” [Heliyon 9, (2023) 16897]
Autores principales: | Shen, Chong, Fu, Chong, Suo, Yong, Li, Kai, Zhang, Zhe, Yang, Shaobo, Zhang, Yu, Lin, Yuda, Li, Zhi, Wu, Zhouliang, Huang, Shiwang, Chen, Houyuan, Fan, Zhenqian, Hu, Hailong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361350/ https://www.ncbi.nlm.nih.gov/pubmed/37484247 http://dx.doi.org/10.1016/j.heliyon.2023.e17229 |
Ejemplares similares
-
Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data
por: Shen, Chong, et al.
Publicado: (2023) -
Withdrawal Notice
Publicado: (2022) -
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
por: Shen, Chong, et al.
Publicado: (2022) -
Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer
por: Shen, Chong, et al.
Publicado: (2023) -
Enhancing urinary tract infection diagnosis for negative culture patients with metagenomic next-generation sequencing (mNGS)
por: Jia, Kaipeng, et al.
Publicado: (2023)